Infoscience

Journal article

Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis

Background and study aims: Low dose photodynamic therapy (LDPDT) may modify the mucosal immune response and may thus provide a therapy for Crohn's disease. We evaluated the efficacy and safety of this technique in a murine T cell-mediated colitis model.

Fulltext

Related material